The invention is concerned with novel 4-aminomethyl benzamidine derivatives of formula (I) wherein Ar and X are as defined in the description and in the claims, as well as prodrugs and pharmaceutically acceptable salts thereof. These compounds inhibit the formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor and can be used as medicaments.
这项发明涉及新颖的式(I)的4-
氨甲基苯甲酰胺衍
生物,其中Ar和X如描述和索赔中定义,以及它们的前药和药学上可接受的盐。这些化合物抑制由VIIa因子和组织因子诱导的
凝血因子Xa、IXa和凝血酶的形成,并可用作药物。